Revenue, last year
€10M
+121.6% vs prior year
Net income
−€90.1M
−52.1% vs prior year
EPS, diluted
−€2.36
−30.7% vs prior year
Operating cash flow
−€69M
−40.1% vs prior year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | €10M | −€90.1M |
| FY24 | €4.5M | −€59.2M |
| FY23 | €4.3M | −€43.2M |
| FY22 | €3.1M | −€31.2M |
| FY21 | €852K | −€27.6M |
| FY20 | €69K | −€12.2M |
| FY19 | - | - |
| FY18 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 63.1% | −833.2% | −899.1% |
| FY24 | 65.7% | −1300.8% | −1310.2% |
| FY23 | 61.9% | −1037.3% | −993.8% |
| FY22 | 62.7% | −1053.8% | −1012.5% |
| FY21 | 64.4% | −3080% | −3241.7% |
| FY20 | 56.5% | −16266.7% | −17746.4% |
| FY19 | - | - | - |
| FY18 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −€69.8M |
| FY24 | −€50.4M |
| FY23 | −€47.3M |
| FY22 | −€29.6M |
| FY21 | −€26.8M |
| FY20 | −€7.4M |
| FY19 | −€6M |
| FY18 | - |
- Nyxoah
- Healthcare median
Show the numbers
| Year | Nyxoah | Healthcare median |
|---|---|---|
| FY25 | −899.1% | −30.6% |
| FY24 | −1310.2% | −47% |
| FY23 | −993.8% | −58% |
| FY22 | −1012.5% | −80.4% |
| FY21 | −3241.7% | −71.8% |
| FY20 | −17746.4% | −62.2% |
| FY19 | - | −46.2% |
| FY18 | - | −49.6% |